Minimally invasive esophagectomy is safe and effective following neoadjuvant chemoradiation therapy

Annals of Surgical Oncology

Volumn 18, Issue 12, 2011, Pages 3324-3329

  Ben David, Kfir ^a   Rossidis, George ^a   Zlotecki, Robert A ^a   Grobmyer, Stephen R ^a   Cendan, Juan C ^a   Sarosi, George A ^a   Hochwald, Steven N ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ANASTOMOSIS; ANASTOMOSIS LEAKAGE; ARTICLE; BLEEDING; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SIZE; CANCER STAGING; CLINICAL ARTICLE; COLITIS; COMPARATIVE STUDY; DATA BASE; DEATH; DEEP VEIN THROMBOSIS; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; HEART ATRIUM FIBRILLATION; HUMAN; LUNG EMBOLISM; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MINIMALLY INVASIVE PROCEDURE; PERIOPERATIVE PERIOD; PNEUMONIA; PROSPECTIVE STUDY; SAFETY; THORACIC DUCT; THORAX; TREATMENT PLANNING; URINARY TRACT INFECTION; WOUND INFECTION;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; CISPLATIN; COMBINED MODALITY THERAPY; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; SURGICAL PROCEDURES, MINIMALLY INVASIVE; SURVIVAL RATE;

EID: 83055179793     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-011-1702-7     Document Type: Article

References (28)

1. Brooks JA, Kesler KA, Johnson CS, Ciaccia D, Brown JW. Prospective analysis of quality of life after surgical resection for esophageal cancer: preliminary Results. J Surg Oncol. 2002;81:185-94.
2. Khuri SF, Henderson WG, De Palma RG, Mosca C, Healey NA, Kumbhani DJ. Determinants of long-term survival after major surgery and the adverse effect of postoperative complications. Ann Surg. 2005;242:341-6.
3. Ku GY, Ilson DH. Role of neoadjuvant therapy for esophageal cancer. Surg Oncol Clin N Am. 2009;18:533-46.
4. Lv J, Cao XF, Zhu B, Ji L, Tao L, Wang DD. Effect of neoadjuvant chemoradiotherapy on prognosis and surgery for esophageal carcinoma. World J Gastroenterology. 2009;15:4962-8.
5. Roof KS, Coen J, Lynch TJ, Wright C, Fidias P, Willett CG, et al. Concurrent cisplatin, 5-FU, paclitaxel, and radiation therapy in patients with locally advanced esophageal cancer. Int J Radiat Oncol Biol Phys. 2006;65:1120-8.
6. De Paula AL, Hashiba K, Ferreira EA, de Paula RA, Grecco E. Laparoscopic transhiatal esophagectomy with esophagogastroplasty. Surg Endosc. 1995;9:681-6.
7. Swanstrom LL. Minimally invasive surgical approaches to esophageal cancer. J Gastrointest Surg. 2002;6:522-6.
8. Luketich JD, Alvelo-Rivera M, Buenaventura PO, Christie NA, McCaughan JS, Litle VR, et al. Minimally-invasive esophagectomy: Outcomes in 222 patients. Ann Surg. 2003;238:486-94.
9. Rice TW. Esophagectomy is the treatment of choice for highgrade dysplasia in Barrett's esophagus. Am J Gastroenterol. 2006;101:2177-84.
10. Orringer MB, Marshall B, Chang AC, Lee J, Pickens A, Lau CL. Two thousand transhiatal esophagectomies: changing trends, lessons learned. Ann Surg. 2007;246:363-72.
11. Siewert JR, Lordick F, Ott K, Stein HJ, Weber WA, Becker K, et al. Induction chemotherapy in Barrett cancer: influence on surgical risk and outcome. Ann Surg. 2007;246:624-8.
12. Birkmyer JD, Siewers AE, Finlayson EV, Stukel TA, Lucas FL, Batista I, et al. Hospital volume and surgical mortality in the United States. N Engl J Med. 2002;346:1128-37.
13. Walsh TN, Noonan N, Hollywood D, Kelly A, Keeling N, Hennessy TP. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med. 1996;335:462-7.
14. Urba SG, Orringer MB, Turrisi A, Iannettoni M, Forastiere A, Strawderman M. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol. 2001;19:305-13.
15. Burmeister BH, Smithers BM, Fitzgerald L, Simes RJ, Devitt P, et al. Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus, a randomized controlled phase III trial. Lancet Oncol. 2005;6:659-68.
16. Natsugoe S, Okumura HM, Uchikado Y, Uchikado Y, Setoyama T, Yokomakura N, et al. Randomized controlled study on preoperative chemoradiotherapy followed by surgery versus surgery alone for esophageal squamous cell cancer in a single institution. Dis Esophagus. 2006;19:468-72.
17. Urschel JD. Esophagogastrostomy anastomotic leaks complicating esophagectomy-a review. Am J Surg. 1995;169:634-40.
18. Keller SM, Ryan LM, Coia LR, Dang P, Vaught DJ, et al. High dose chemoradiotherapy followed by esophagectomy for adenocarcinoma of the esophagus and gastroesophageal junction: results of a phase II study of the Eastern Cooperative Oncology Group. Cancer. 1998;83:1908-16.
19. Avendano CE, Flume PA, King LB, Reed CE. Pulmonary complications after esophagectomy. Ann Thorac Surg. 2002;73:922-6.
20. Schilling MK, Eichenberger M, Maurer CA, Sigurdsson G, Büchler MW. Ketoconazole and pulmonary failure after esophagectomy: a prospective clinical trial. Dis Esophagus. 2001;14:37-40.
21. Nguyen NT, Hinojosa MW, Smith BR, Chang KJ, Gray J, Hoyt D. Minimally invasive esophagectomy: lessons learned from 104 operations. Ann Surg. 2008;248:1081-91.
22. Palanivelu C, Prakash A, Senthilkumar R, Senthilnathan P, Parthasarathi R, Rajan PS, et al. Minimally invasive esophagectomy: thoracoscopic mobilization of the esophagus and mediastinal lymphadenectomy in prone position-experience of 130 patients. J Am Coll Surg. 2006;203:7-16.
23. Díaz R, Reynes G, Tormo A, de Juan M, Gironés R, Segura A, et al. Long-term results of neoadjuvant chemotherapy and combined chemoradiotherapy before surgery in the management of locally advanced oesophageal cancer: a single-centre experience. Clin Transl Oncol. 2009;11:835-41.
24. Mak RH, Mamon HJ, Ryan DP, Miyamoto DT, Ancukiewicz M, Kobayashi WK, et al. Toxicity and outcomes after chemoradiation for esophageal cancer in patients age 75 or older. Dis Esophagus. 2010;23:316-23.
25. Griffin SM, Shaw IH, Dresner SM. Early complications after Ivor Lewis subtotal esophagectomy with two-field lymphadenectomy: risk factors and management. J Am Coll Surg. 2002;194:285-97.
26. Rindani R, Martin CJ, Cox MR. Transhiatal versus Ivor-Lewis oesophagectomy: is there a difference? Aust N Z J Surg. 1999;69:187-94.
27. Kohn GP, Galanko JA, Meyers MO, Feins RH, Farrell TM. National trends in esophageal surgery-are outcomes as good as we believe? J Gastrointest Surg. 2009;13:1900-10.
28. Khithani A, Jay J, Galanopoulos C, Curtis D, Vo A, Jeyarajah DR. Zero leaks with minimally invasive esophagectomy: a teambased approach. JSLS. 2009;13:542-9.